Quick reference
Iboga and Ibogaine quick reference
A compact orientation to the plant, the alkaloid, the metabolite, evidence, safety, law, culture, and media records.
Core distinctions
- Iboga
- Tabernanthe iboga and related Central African cultural, ecological, conservation, and stewardship contexts.
- Ibogaine
- A psychoactive indole alkaloid studied for opioid withdrawal, substance use, TBI-related symptoms, and other neuropsychiatric questions, with serious safety and legal constraints.
- Noribogaine
- A metabolite and drug-development focus. FDA permission for an investigational study is not FDA approval and does not establish safety or effectiveness.
- Analogs
- 18-MC, tabernanthalog, and related derivatives are tracked by molecule, sponsor, evidence type, and clinical status. They are not interchangeable with Iboga or Ibogaine.
Reader boundary
This is not medical advice or legal advice. Ibogaine remains Schedule I federally in the United States, is not FDA-approved as a treatment, and carries serious cardiac and interaction risks. Emergency, treatment, and legal decisions belong with qualified professionals and local emergency systems.